- Oragenics (NYSE:OGEN) on Tuesday said it has entered into a placement agency agreement for the purchase and sale of 1.1M shares of common stock at $1.00 per share.
- The gross proceeds of the offering are anticipated to be about $1.1M before deducting placement agent fees and other estimated offering expenses payable by the company.
- The company intends to use the net proceeds from the offering to fund the continued development of its ONP-002 product candidate and for general corporate purposes and working capital.
- The offering is expected to close on or about June 26, 2024.
- Press release.
Oragenics prices public offering of common stock
